Exploratory Biomarker Analyses Support Frexalimab Mechanism of Action in Participants with Relapsing Multiple Sclerosis
MULTIPLE SCLEROSIS JOURNAL(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined